v3.25.4
Condensed Consolidated Statements of Stockholders’ Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Treasury Stock Amount
 [3]
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023 [1]   175,462,000        
Beginning balance at Dec. 31, 2023 $ 169,137 $ 19 [1] $ 770,196   $ 48 $ (601,126)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 2,119   2,119      
Foreign currency translation adjustment 6       6  
Unrealized gain on available-for-sale securities (35)       (35)  
Net loss (13,637)         (13,637)
Ending balance (in shares) at Mar. 31, 2024 [1]   175,462,000        
Ending balance at Mar. 31, 2024 157,590 $ 19 [1] 772,315   19 (614,763)
Beginning balance (in shares) at Dec. 31, 2023 [1]   175,462,000        
Beginning balance at Dec. 31, 2023 169,137 $ 19 [1] 770,196   48 (601,126)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Foreign currency translation adjustment (7)          
Unrealized gain on available-for-sale securities (31)          
Net loss (47,630)          
Ending balance (in shares) at Sep. 30, 2024 [1]   175,462,000        
Ending balance at Sep. 30, 2024 127,399 $ 19 [1] 776,126   10 (648,756)
Beginning balance (in shares) at Mar. 31, 2024 [1]   175,462,000        
Beginning balance at Mar. 31, 2024 157,590 $ 19 [1] 772,315   19 (614,763)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 1,979   1,979      
Foreign currency translation adjustment (4)       (4)  
Unrealized gain on available-for-sale securities (9)       (9)  
Net loss (16,937)         (16,937)
Ending balance (in shares) at Jun. 30, 2024 [1]   175,462,000        
Ending balance at Jun. 30, 2024 142,619 $ 19 [1] 774,294   6 (631,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 1,832   1,832      
Foreign currency translation adjustment (9)       (9)  
Unrealized gain on available-for-sale securities 13       13  
Net loss (17,056)         (17,056)
Ending balance (in shares) at Sep. 30, 2024 [1]   175,462,000        
Ending balance at Sep. 30, 2024 $ 127,399 $ 19 [1] 776,126   10 (648,756)
Beginning balance (in shares) at Dec. 31, 2024 164,087,277 [2] 164,087,000 [3]        
Beginning balance at Dec. 31, 2024 $ 111,183 $ 19 [3] 769,866 $ (1) 21 (658,722)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 247   247      
Foreign currency translation adjustment 4       4  
Unrealized gain on available-for-sale securities (14)       (14)  
Net loss (11,250)         (11,250)
Ending balance (in shares) at Mar. 31, 2025 [3]   164,087,000        
Ending balance at Mar. 31, 2025 $ 100,170 $ 19 [3] 770,113 (1) 11 (669,972)
Beginning balance (in shares) at Dec. 31, 2024 164,087,277 [2] 164,087,000 [3]        
Beginning balance at Dec. 31, 2024 $ 111,183 $ 19 [3] 769,866 (1) 21 (658,722)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Foreign currency translation adjustment 21          
Unrealized gain on available-for-sale securities (16)          
Net loss $ (25,681)          
Ending balance (in shares) at Sep. 30, 2025 163,296,812 [2] 164,087,000 [3]        
Ending balance at Sep. 30, 2025 $ 85,879 $ 19 [3] 770,238 (1) 26 (684,403)
Beginning balance (in shares) at Mar. 31, 2025 [3]   164,087,000        
Beginning balance at Mar. 31, 2025 100,170 $ 19 [3] 770,113 (1) 11 (669,972)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation (46)   (46)      
Foreign currency translation adjustment (15)       (15)  
Unrealized gain on available-for-sale securities (2)       (2)  
Net loss (7,849)         (7,849)
Ending balance (in shares) at Jun. 30, 2025 [3]   164,087,000        
Ending balance at Jun. 30, 2025 92,258 $ 19 [3] 770,067 (1) (6) (677,821)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 171   171      
Foreign currency translation adjustment 32       32  
Unrealized gain on available-for-sale securities 0          
Net loss $ (6,582)         (6,582)
Ending balance (in shares) at Sep. 30, 2025 163,296,812 [2] 164,087,000 [3]        
Ending balance at Sep. 30, 2025 $ 85,879 $ 19 [3] $ 770,238 $ (1) $ 26 $ (684,403)
[1] Shares issued and outstanding exclude 738,000 Sponsor Shares subject to vesting requirements.
[2] Shares issued and outstanding exclude 738,000 shares subject to vesting requirements held by TS Innovation Acquisitions Sponsor, L.L.C. (the “Sponsor”) related to the 2021 business combination (the “Sponsor Shares”).
[3] Shares issued and outstanding exclude 738,000 Sponsor Shares subject to vesting requirements.